Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide Treatment and Using a Population of Patients With Multiple Sclerosis as a Reference.

Trial Profile

Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide Treatment and Using a Population of Patients With Multiple Sclerosis as a Reference.

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Feb 2013

At a glance

  • Drugs Teriflunomide (Primary) ; Influenza virus vaccine; Interferon beta-1
  • Indications Influenza virus infections; Multiple sclerosis
  • Focus Pharmacodynamics
  • Acronyms TERIVA
  • Most Recent Events

    • 03 Feb 2012 Actual patient number added 128 according to ClinicalTrials.gov.
    • 03 Feb 2012 Actual end date (January 2012) added as reported by ClinicalTrials.gov.
    • 03 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top